Iridian Asset Management LLC Viatris Inc Transaction History

Iridian Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$9.81 - $15.4 $634,579 - $996,179	-64,687 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$12.09 - $14.68 $54.3 Million - $65.9 Million	-4,489,971 Reduced 98.58%	64,687 $875,000
Q3 2021 Nov 10, 2021	SELL	$13.25 - $15.13 $36.3 Million - $41.4 Million	-2,738,058 Reduced 37.55%	4,554,658 $61.7 Million
Q2 2021 Aug 11, 2021	SELL	$12.97 - $16.15 $1.65 Million - $2.05 Million	-126,896 Reduced 1.71%	7,292,716 $104 Million
Q1 2021 May 11, 2021	BUY	$13.59 - $18.54 $4.71 Million - $6.42 Million	346,344 Added 4.9%	7,419,612 $104 Million
Q4 2020 Feb 08, 2021	BUY	$14.3 - $18.74 $101 Million - $133 Million	7,073,268 New	7,073,268 $133 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Iridian Asset Management LLC with notifications on news.